GlassScriptPhysician profile
Srinivas Reddy
NPI 1861926354
$449.48
in general payments reported to CMS, 2019-2025
9 companies · $19.94 in 2025
The $19.94 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.46 · 2021: $211 · 2022: $30.75 · 2023: $48.11 · 2024: $54.94 · 2025: $19.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $125.00 | 2021 | |
| Edwards Lifesciences Corporation | $84.46 | 2019 | |
| Janssen Products, LP | $69.99 | 2021 | |
| Janssen Biotech, INC. | $62.22 | 2021-2023 | Symtuza |
| Gilead Sciences, INC. | $41.72 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $19.94 | 2025 | Zerbaxa |
| Boston Scientific Corporation | $18.85 | 2024 | Varithena Administration Pack |
| La Jolla Pharmaceutical Company | $13.76 | 2023 | Xerava |
| Cumberland Pharmaceuticals, INC. | $13.54 | 2024 | Vibativ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.